Systemic Sclerosis after Interferon Alphacon-1 Therapy for Hepatitis C-Reference-Cited by-同舟云学术

Systemic Sclerosis after Interferon Alphacon-1 Therapy for Hepatitis C

Published:2007 Issue:8 Volume:46 Page:473-476
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Tahara Hiroki¹,Kojima Akira¹,Hirokawa Tomoyuki¹,Oyama Tatsuya¹,Naganuma Atsushi¹,Maruta Sakae¹,Okada Katsuyuki²,Ban Satoshi³,Yoshida Katsue³,Takagi Hitoshi⁴,Mori Masatomo⁴

Affiliation:

1. Department of Internal Medicine, Kiryu Kosei General Hospital, Kiryu

2. Department of Dermatology, Kiryu Kosei General Hospital, Kiryu

3. Department of Pathology, Kiryu Kosei General Hospital, Kiryu

4. Department of Medicine and Molecular Science, Gunma University School of Medicine, Maebashi

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/46/8/46_8_473/_pdf

Reference26 articles.

1. 1. Yasuda S, Miyata K. Interferon alfacon-1(Advaferon): a novel synthetic interferon for the treatment of hepatitis C, its pharmacological and clinical profile. Nippon Yakurigaku Zasshi 120: 421-426, 2002(in Japanese, Abstract in English).

2. 2. Doi F, Kakizaki S, Takagi H et al. Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C. Liver Int 25: 242-246, 2005.

3. 3. Niewold TB, Swedler WI. Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C. Clin Rheumatol 24: 178-181, 2005.

4. 4. Okanoue T, Sakamoto S, Itoh Y et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 25: 283-291, 1996.

5. 5. Ioannou Y, Isenberg DA. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum 43: 1431-1442, 2000.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like Receptor Homologue CD180 Ligation of B Cells Upregulates Type I IFN Signature in Diffuse Cutaneous Systemic Sclerosis;International Journal of Molecular Sciences;2024-07-20

2. Interferons dominate damage and activity in juvenile scleroderma;Modern Rheumatology;2024-04-06

3. Infections and Systemic Sclerosis;Infection and Autoimmunity;2024

4. Molecular Mechanisms Behind the Role of Plasmacytoid Dendritic Cells in Systemic Sclerosis;Biology;2023-02-10

5. Anifrolumab in systemic lupus erythematosus;Drugs of Today;2023-02